BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33242149)

  • 1. Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis.
    Beltrán E; Paunovic M; Gebert D; Cesur E; Jeitler M; Höftberger R; Malotka J; Mader S; Kawakami N; Meinl E; Bradl M; Dornmair K; Lassmann H
    Acta Neuropathol; 2021 Jan; 141(1):67-83. PubMed ID: 33242149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion.
    Salvador F; Deramoudt L; Leprêtre F; Figeac M; Guerrier T; Boucher J; Bas M; Journiac N; Peters A; Mars LT; Zéphir H
    Front Immunol; 2022; 13():755900. PubMed ID: 35185870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Stefferl A; Brehm U; Linington C
    J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.
    Raine CS; Cannella B; Hauser SL; Genain CP
    Ann Neurol; 1999 Aug; 46(2):144-60. PubMed ID: 10443879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
    Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
    J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of IL-17 Serum Level, Brain Inflammation and Demyelination in Experimental Autoimmune Encephalomyelitis C57BL/6 Mice Model with Different Doses of Myelin Oligodendrocyte Glycoprotein.
    Ghorbani MM; Farazmandfar T; Nasirikenari M; Abediankenari S; Meamarian A; Shahbazi M
    Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):300-309. PubMed ID: 31522437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
    Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
    Adelmann M; Wood J; Benzel I; Fiori P; Lassmann H; Matthieu JM; Gardinier MV; Dornmair K; Linington C
    J Neuroimmunol; 1995 Dec; 63(1):17-27. PubMed ID: 8557821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
    Kinzel S; Lehmann-Horn K; Torke S; Häusler D; Winkler A; Stadelmann C; Payne N; Feldmann L; Saiz A; Reindl M; Lalive PH; Bernard CC; Brück W; Weber MS
    Acta Neuropathol; 2016 Jul; 132(1):43-58. PubMed ID: 27022743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
    Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
    J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
    Kap YS; van Driel N; Arends R; Rouwendal G; Verolin M; Blezer E; Lycke N; 't Hart BA
    Clin Exp Immunol; 2015 Apr; 180(1):28-39. PubMed ID: 25393803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3d binding to the myelin oligodendrocyte glycoprotein results in an exacerbated experimental autoimmune encephalomyelitis.
    Jégou JF; Chan P; Schouft MT; Griffiths MR; Neal JW; Gasque P; Vaudry H; Fontaine M
    J Immunol; 2007 Mar; 178(5):3323-31. PubMed ID: 17312184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
    Faber H; Kurtoic D; Krishnamoorthy G; Weber P; Pütz B; Müller-Myhsok B; Weber F; Andlauer TFM
    Front Immunol; 2020; 11():2165. PubMed ID: 33072080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Delarasse C; Smith P; Baker D; Amor S
    Immunology; 2013 Dec; 140(4):456-64. PubMed ID: 23876060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.